Abu Dhabi health department signs agreements and publishes AI clinician framework
On 21 October the Department of Health – Abu Dhabi signed agreements on life sciences research, personalised prevention and AI-driven drug discovery, in the presence of Theyab bin Mohamed bin Zayed. On 20 October it published the AI Clinician Framework for the responsible study of AI clinician systems.
Who is affected and how
- health policy
- The AI clinician framework is an example of regulatory oversight of research into AI medical systems.
- pharmaceuticals
- The AI drug discovery agreements open up new collaboration opportunities in the Gulf region.
Sources
- In the presence of Theyab bin Mohamed bin Zayed, Department of Health – Abu Dhabi signs agreements to advance research in life sciences, personalised preventive health, and AI drug discoveryمكتب أبوظبي الإعلامي · Oct 21, 2026
- Abu Dhabi to advance AI-driven drug discovery under new agreementarn news centre · Oct 21, 2026
- Department of Health – Abu Dhabi, Isomorphic Labs collaborate to advance AI drug discovery research | Emirates News Agencywam.ae · Oct 21, 2026
- Abu Dhabi to advance AI-driven drug discovery under new agreement - City 1016city1016.ae · Oct 21, 2026
- Abu Dhabi signs AI drug discovery and clinical trial deals worth $50 millionontimebrief.com · Oct 21, 2026
- Department of Health – Abu Dhabi and WHOOP Announce Strategic Research Collaboration to Advance the Future of Personalised Preventive Healthgulftech-news.com · Oct 22, 2026
- Abu Dhabi Partners with Isomorphic Labs for AI Drug Designgopularam.com · Oct 22, 2026
- Boehringer and Microsoft collaborate to explore AI in clinical researchpharmaceutical technology · Oct 23, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.